Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Vimta LabsBOM:524394 +3.58%84 Dividend Payout Ratio is 0.43 as of Jun. 2026, which is 378% above its 10-year median of 0.09. GuruFocus rates BOM:524394 with a GF Score™ of 84/100 and a GF Value™ of ₹495.16 (Modestly Overvalued). The stock has 1 warning sign investors should review. Among 52 Medical Diagnostics & Research companies, Vimta Labs ranks better than 92.31% on this metric.
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Vimta Labs's Dividend Payout Ratio for the
months ended in Jun. 2026 was 0.43.
The historical rank and industry rank for Vimta Labs's Dividend Payout Ratio or its related term are showing as below:
BOM:524394'
s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.05 Med: 0.09 Max: 0.58
Current: 0.11
During the past 13 years, the highest Dividend Payout Ratio of Vimta Labs was 0.58. The lowest was 0.05. And the median was 0.09.
BOM:524394's Dividend Payout Ratio is ranked better than 92.31% of 52
companies
in the Medical Diagnostics & Research industry
Industry Median: 0.52
vs BOM:524394: 0.11
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Vimta Labs was 71.00% per year. The lowest was -20.60% per year. And the median was 0.00% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Vimta Labs (BOM:524394) Dividend Payout Ratio Explanation
In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Vimta Labs Dividend Payout Ratio Related Terms
Vimta Labs Dividend Payout Ratio Historical Data
* Premium members only.
The historical data trend for Vimta Labs's Dividend Payout Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:524394 vs TMO, DHR, IDXX: Dividend Payout Ratio Comparison
For the Diagnostics & Research subindustry, Vimta Labs's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vimta Labs Dividend Payout Ratio vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Vimta Labs's Dividend Payout Ratio distribution charts can be found below:
* The bar in red indicates where Vimta Labs's Dividend Payout Ratio falls into.
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.
Vimta Labs's Dividend Payout Ratio for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vimta Labs (BOM:524394) has a Dividend Payout Ratio of 0.43 as of Jun. 2026. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Vimta Labs and its competitors. This is 378% above median its historical median of 0.09. Over the past decade, Vimta Labs' Dividend Payout Ratio has ranged from 0.05 to 0.58. According to the industry distribution chart, Vimta Labs ranks #4 out of 52 companies in the Medical Diagnostics & Research industry, placing it in the top 7.7%.
Is Vimta Labs' Dividend Payout Ratio too high?
Vimta Labs' current Dividend Payout Ratio of 0.43 is 378% above median its 10-year median of 0.09. Over the past 10 years, this metric has ranged from a low of 0.05 to a high of 0.58. The Medical Diagnostics & Research industry median Dividend Payout Ratio is 0.52. Vimta Labs' value of 0.43 is 17.3% below this industry median. Based on the distribution chart, Vimta Labs ranks #4 out of 52 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Vimta Labs has a GF Score™ of 84/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Vimta Labs' Dividend Payout Ratio compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Vimta Labs ranks #4 out of 52 companies for Dividend Payout Ratio. This places Vimta Labs in the top 8% of its industry — outperforming the majority of peers. The industry median Dividend Payout Ratio is 0.52. Vimta Labs' value of 0.43 is 17.3% below this benchmark. Historically, Vimta Labs' own Dividend Payout Ratio has ranged from 0.05 to 0.58 over the past decade. While the company's 10-year median is 0.09 vs. the industry median of 0.52, Vimta Labs has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Medical Diagnostics & Research company?
The median Dividend Payout Ratio among Medical Diagnostics & Research companies is 0.52, based on 52 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vimta Labs's current Dividend Payout Ratio of 0.43 is 17.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Vimta Labs and its competitors. For the Medical Diagnostics & Research industry, the median Dividend Payout Ratio is 0.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vimta Labs's current Dividend Payout Ratio is 0.43, which is 378% above median its own 10-year median of 0.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vimta Labs stock overvalued right now?
Based on GuruFocus' analysis, Vimta Labs (BOM:524394) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹495.16, compared to a current price of ₹641.20 — trading 29.5% above its estimated fair value. The current Dividend Payout Ratio is 0.43, which is 378% above median its 10-year median of 0.09 and 17.3% below the Medical Diagnostics & Research industry median of 0.52. Vimta Labs' overall GF Score™ is 84/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For Vimta Labs (BOM:524394), the current Dividend Payout Ratio is 0.43 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vimta Labs (BOM:524394) Overvalued in 2026?
Based on GuruFocus' analysis, Vimta Labs stock appears to be overvalued.
The current stock price of ₹641.20 is trading 29.5% above its estimated GF Value™ of ₹495.16.
GuruFocus considers Vimta Labs to be Modestly Overvalued.
Key valuation signals for BOM:524394:
Dividend Payout Ratio: 0.43 (378% above median its 10-year median of 0.09)
GF Value™: ₹495.16 vs. price of ₹641.20 (29.5% above fair value)
Industry Position: 17.3% below the Medical Diagnostics & Research median (#4 of 52)
No single metric tells the full story. See the BOM:524394 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vimta Labs Ltd is a comprehensive contract research and testing organization, providing a wide range of services to pharmaceutical, biopharmaceutical, food, consumer goods, electronic, electrical, agrochemical, healthcare, medical device, and many other industries. Its services portfolio includes testing and contract research services in the fields of clinical research, pre-clinical research, clinical diagnostics, biopharma services, analytical testing, research and environmental studies, and Others. It has only one reportable segment namely Contract Research and Testing Services which generates the revenue.
84GF Score
Get the complete analysis for BOM:524394
Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524394 has been successfully added to your 
